Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central nervous effects of exendin-4 on hunger and satiety in obesity and type 2 diabetes
2007-007970-47Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Aug 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of exenatide in obesity and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Leipzig University. Primary endpoint: Neuronal activity changes in brain regions controlling feeding behavior. Started Aug 2009; status: completed.
02
Drugs
exenatide
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-007970-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007970-47.